Vitrectomía enzimática por inyección intravítrea de plasmina autóloga como tratamiento inicial de las membranas epirretinianas maculares y el síndrome de tracción vitreomacular;Enzymatic vitrectomy by intravitreal autologous plasmin injection as initial treatment for macular epiretinal membranes and vitreomacular traction syndrome

Archivos de la Sociedad Espanola de Oftalmologia

Volumn 84, Issue 2, 2009, Pages 91-100

  Diaz Llopis M ^a,b,c,g   Udaondo, P ^a,b,c   Cervera, E ^d   Garcia Delpech S ^c   Salom, D ^a,b,c   Quijada, A ^b   Romero, F J ^e,f  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

^c UNIVERSIDAD CATÓLICA DE VALENCIA SAN VICENTE MÁRTIR   (Spain)

^d HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

^e UNIVERSIDAD SAN PABLO CEU   (Spain)

^f Fundación Oftalmológica Del Mediterráneo FOM   (Spain)

^g Manuel Díaz Llopis   (Spain)

Author keywords

Autologous plasmin; Enzimatic vitrectomy; Enzymatic vitreolysis; Epiretinal membrane; Macular pucker; Pharmacologic vitreolysis; Vitreomacular traction syndrome

Indexed keywords

PLASMIN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; DRUG EFFECT; EPIRETINAL MEMBRANE; FEMALE; HUMAN; INJECTION; ISOLATION AND PURIFICATION; MALE; METHODOLOGY; MIDDLE AGED; OPTICAL COHERENCE TOMOGRAPHY; PILOT STUDY; PROSPECTIVE STUDY; RETINA DISEASE; VISUAL ACUITY; VITRECTOMY; VITREOUS BODY;

ADULT; AGED; AGED, 80 AND OVER; EPIRETINAL MEMBRANE; FEMALE; HUMANS; INJECTIONS; MALE; MIDDLE AGED; PILOT PROJECTS; PLASMIN; PROSPECTIVE STUDIES; RETINAL DISEASES; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY; VITRECTOMY; VITREOUS BODY;

EID: 67749127883     PISSN: 03656691     EISSN: None     Source Type: Journal    
DOI: 10.4321/S0365-66912009000200007     Document Type: Article

References (68)

1. Koerner F, Garweg J. Diseases of vítreo-macular interface. Klin Monatsbl Augenheilkd 1999; 214: 305-310.
2. Clarkson JG, Green WR, Massot D. A histopathologic review of 168 cases of preretinal membrane. Am J Oph-thalmol 1977; 84: 1-17.
3. Gailit J, Clark RAF. Wound repair in the context of extracellular matrix. Curr Opin Cell Biol 1994; 6: 717-725.
4. Wiedemann P, Heimann K. Proliferative vitreoretinopathy. Curr Opin Ophthalmol 1992; 3: 357-365.
5. Messmer EM, Heidenkummer HP, Kampik A. Ultraestruc-ture of epiretinal membranes associated with macular holes. Graefes Arch Clin Exp Ophthalmol 1998; 236: 248-254.
6. Immonen I, Vaheri A, Tommila P, Siren V. Plasminogen activation in epiretinal membranas. Graefe's Arch Clin Exp Ophthalmol 1996; 234: 664-669.
7. Greven CM, Slusher MM, Weaver RG. Epiretinal membrane release and posterior vitreous detachment. Ophthalmology 1988; 95: 902-905.
8. Garay-Aramburu G, Larrauri-Arana A. Resolución espontánea de membrana epirretiniana idiopática en un paciente joven. Arch Soc Esp Oftalmol 2005; 80: 741-743.
9. Hikichi T, Yoshida A, Trempe Ch. Course of vitreomacular traction syndrome. Am J Ophthalmol 1995; 119: 55-61.
10. Sarup V, Wald KJ, Gross NE, Athanikar AN, Siringo F. Spontaneous resolution of unilateral vitreomacular traction. Ann Ophthalmol 2006; 38: 347-349.
11. Levy J, Klemperer I, Belfair N, Rogozin A, Liftshitz T. Rapid spontaneous resolution of vitreomacular traction syndrome documented by optical coherence tomography. Int Ophthalmol 2004; 25: 247-251.
12. Rodriguez A, Infante R, Rodriguez EJ, Valencia M. Spontaneous separation in idiopathic vitreomacular traction syndrome associated with contralateral full-thickness macular hole. Eur J Ophthalmol 2006; 16: 733-740.
13. Carpineto P, Ciancaglini M, Aharrh-Gnama A, Agnifili L, Mastropasqua L. Optical coherence tomography and retinal thickness. Analyzer features of spontaneous resolution of vitreomacular traction syndrome. A case report. Eur J Ophthalmol 2004; 14: 67-70.
14. Maguluri S, Recchia FM. Resolution of tractional macular edema following spontaneous detachment of residual vitreous cortex in a vitrectomized eye. Ophthalmic Surg Laser 2008; 39: 63-64.
15. Rizzo S, Pellegrini G, Benocci F, Belting C, Baicchi M. Autologous plasmin for pharmacologic vitreolysis prepared 1 hour before surgery. Retina 2006; 26: 792-796.
16. Tanaka M, Qui H. Pharmacological vitrectomy. Semin Ophthalmol 2000; 15: 51-61.
17. Alió J, Sánchez A, Ludeña S, García S, Bergés J, Batlle J. Vitreolisis enzimática: estudio experimental de un nuevo método no mecánico de vitrectomia. Arch Soc Esp Oftal 1987; 53: 349-360.
18. Trese MT. Enzymatic-assisted vitrectomy. Eye 2002; 16: 365-368.
19. Sebag J. Molecular biology of pharmacologic vitreolysis. Trans Am Ophthalmol Soc 2005; 103: 473-493.
20. Verstraten TC, Chapman C, Hartzer M, Winkler BS, Trese MT, Williams GA. Pharmacological induction of posterior vitreous detachment in the rabbit. Arch Ophthalmol 1993; 111: 849-854.
21. Kohno T Sorgente N, Patterson R, Ryan SJ. Fibronectin and laminin distribution in bovine eye. Jpn J Ophthalmol 1983; 27: 496-505.
22. Kohno T, Sorgente N, Ishibashi T, Goodnight R, Ryan SJ. Immunofluorescent studies of fibronectin and laminin in the human eye. Invest Ophthalmol Vis Sci 1987; 28: 506-514.
23. Liotta LA, Goldfarb RH, Terranova VP. Cleavage of laminin by thrombin and plasmin: alpha thrombin selectively cleaves the beta chain of laminin. Thromb Res 1981; 21: 663-673.
24. Hikichi T Yanagiya N, Kado M, Akiba J, Yoshida A. Posterior vitreous detachment induced by injection of plasmin and sulfur hexafluoride in the rabbit vitreous. Retina 1999; 19: 55-58.
25. Li X, Shi X, Fan J. Posterior vitreous detachment with plasmin in the isolated human eye. Graefes Arch Clin Exp Ophthalmol 2002; 240: 56-62.
26. Gandofer A, Putz E, Welge-Lupben U, Grüterich M, Ulbig M, Kampik A. Ultrastructure of the vitreoretinal interface following plasmin assisted vitrectomy. Br J Ophthalmol 2001; 85: 6-10.
27. Asami T, Terasaki H, Kachi S, Nakamura M, Yamamura K, Nabeshima T, et al. Ultrastructure of internal limiting membrane removed during plasmin assisted vitrectomy from eyes with diabetic macular edema. Ophthalmology 2004; 111: 231-237.
28. Trese MT, Williams GA, Hartzer MK. A new approach to stage 3 macular hole. Ophthalmology 2000; 107:1607-1611.
29. Sakuma T, Tanaka M, Inoue J, Mizota A, Souri M, Ichino-se A. Use of autologous plasmin during vitrectomy for diabetic maculopathy. Eur J Ophthalmol 2006; 16: 138-140.
30. Sakuma T, Takana M, Inoue J, Mizota A, Sauri M, Achinóse A. Efficacy of autologous plasmin for idiopathic macular hole surgery. Eur J Ophthalmol 2005; 15: 787-794.
31. Azzolini C, D 'Angelo A, Maestranzi G, Codenotti M, Delia Valle P, Prati M, et al. Intrasurgical plasmin in diabetic macular edema. Am J Ophthalmol 2004; 138: 560-568.
32. Williams JG, Trese MT, Williams GA, Hartzer MK. Autologous plasmin enzyme in the surgical management of diabetic retinopathy. Ophthalmology 2001; 108: 1902-1905.
33. Margherio AR, Margherio RR, Hartzer M, Trese MT, Williams GA, Ferrone PJ. Plasmin enzyme-assisted vitrectomy in traumatic pediatric macular holes. Ophthalmology 1998; 105: 1617-1620.
34. Tsukahara Y, Honda S. Autologous plasmin-assisted vitrectomy for stage 5 retinopathy of prematurity. Am J Ophthalmol 2007; 144: 139-141.
35. Diaz-Llopis M, Udaondo P, García-Delpech S, Salom D, Cervera E, Quijada A. Vitrectomía enzimática por inyección intravítrea de plasmina autóloga como tratamiento inicial del edema macular diabético difuso. Arch Soc Esp Oftalmol 2008; 83: 77-84.
36. Udaondo P, Diaz-Llopis M, García-Delpech S, Cervera E, Salom D. Plasmina autóloga para inyección intravítrea sin vitrectomía asociada: método simplificado de preparación con streptokinasa. Arch Soc Esp Oftalmol 2008; 83: 153-154.
37. Diaz-Llopis M, Udaondo P, Salom D, García-Delpech S, Romero FJ. Plasmina autóloga intravítrea sin asociar vitrectomia. Vitreolisis farmacológica, método perfeccionado con uroquinasa. Arch Soc Esp Oftalmol 2008; 83: 291-292.
38. Unal M, Peyman GA. The efficacy of plasminogen-uroki-nase combination in inducing posterior vitreous detachment. Retina 2000; 20: 69-75.
39. Men G, Peyman GA, Genaidy M, Kuo PC, Ghahramani F, Blake DA, Bezerra Y, Naaman G, Figueiredo E. The role of recombinant lysine-plasminogen and recombinant uroki-nase and sulfur hexafluoride combination in inducing posterior vitreous detachment. Retina 2004; 24: 199-209.
40. Sakuma T, Tanaka M, Saouri M, Ichinose A. Preparation of high-purity and safe autologous plasmin and its clinical application. Nippon Ganka Gakkai Zasshi 2003; 107: 709-718.
41. Treese MT. Enzymatic vitreous surgery. Semin Ophthalmol 2000; 15: 161-121.
42. Johnson MW. Tractional cystoid macular edema: a subtle variant of the vitreomacular traction syndrome. Am J Ophthalmol 2005; 140:184-192.
43. Melberg NS, Williams DF, Bailes MW, Jaffe GJ, Meredith TA, Sneed SR, Westrich DJ. Vitrectomy for vitreomacular traction syndrome with macular detachment. Retina 1995; 15: 192-197.
44. Pournaras CJ, Kapetanios AD, Donati G. Vitrectomy for traction macular edema. Doc Ophthalmol 1999; 97: 439-447.
45. McDonald HR, Johnson RN, Schatz H. Surgical results in the vitreomacular traction syndrome. Ophthalmology 1994; 101: 1397-1402.
46. Yamada N, Kishi S. Tomographic features and surgical outcomes of vitreomacular traction syndrome. Am J Ophthalmol 2005; 139: 112-117.
47. Do DV, Cho M, Nguyen QD, Shah SM, Handa JT, Campo-chiaro PA, et al. Impact of optical coherence tomography on surgical decision making for epiretinal membranes and vitreomacular traction. Retina 2007; 27: 552-556.
48. Mirza RG, Johnson MW, Jampol LM. Optical coherence tomography use in evaluation of the vitreoretinal interface: a review. Surv Ophthalmol 2007; 52: 397-421.
49. Wiznia RA. Natural history of idiopathic preretinal macular fibrosis. Ann Ophthalmol 1982; 14: 876-878.
50. Wise GN. Relationship of idiopathic preretinal macular fibrosis to posterior vitreous detachment. Am J Ophthalmol 1975; 79: 358-362.
51. Hirokawa H, Jalkh AE, Takahashi M, Takahashi M, Trem-pe CL, Schepens CL. Role of the vitreous in idiopathic preretinal macular fibrosis. Am J Ophthalmol 1986; 101: 166-169.
52. Wiznia RA. Posterior vitreous detachment and idiopathic preretinal macular gliosis. Am J Ophthalmol 1986; 102: 196-198.
53. Fang X, Chen Z, Weng Y, Shu Z, Ni H, Jiang J, et al. Surgical outcome after removal of idiopathic epiretinal membrane in young patients. Eye 2008; 22: 1430-1435.
54. Heilskov TW, Massicotte SJ, Folk JC. Epiretinal macular membranes in eyes with attached posterior cortical vitreous. Retina 1996; 16: 279-284.
55. Koizumi H, Spaide RF, Fisher YL, Freund KB, Klancnik JM, Yanuzzi LA. Three-dimensional evaluation of vitreomacular traction and epiretinal membrane using spectral-domain optical coherence tomography. Am J Ophthalmol 2008; 145: 509-517.
56. Simiddy WE, Maguire AM, Green WR. Idiopathic epiretinal membranes. Ultraestructural characteristics and clinicopa-thologic correlation. Ophthalmology 1989; 96: 811-820.
57. Smiddy WE, Green WR, Michels RG, De la Cruz Z. Ultras-tructural studies of vitreomacular traction syndrome. Am J Ophthalmol 1989; 107: 177-185.
58. Shinoda K, Hirakata A, Hida T, Yamaguchi Y, Fukuda M, Maekawa S, et al. Ultrastructural and immunohistochemical findings in five patients with vitreomacular traction syndrome. Retina 2000; 20: 289-293.
59. Kampik A, Green WR, Michaels RG, Nase PK Ultrastructural features of progressive idiopathic epiretinal membrane removed by vitreous surgery. Am J Ophthalmol 1980; 90: 797-809.
60. Gandorfer A, Rohleder M, Kampik A. Epiretinal pathology of vitreomacular traction syndrome. Br J Ophthalmol 2002; 86: 902-909.
61. Lee MW, Cheng Bobby CL, Ang CL. Optical coherence tomography evidence of rapid progression from vitreo macular traction to full thickness macular hole. Clin Exp Ophthalmol 2007; 35: 379-380.
62. Wang F, Wang Z, Sun X, Wang F, Xu X, Zhang X. Safety and efficacy of dispase and plasmin in pharmacologic vitreoly-sis. Invest Ophthalmol Vis Sci 2004; 45: 3286-3290.
63. Gandorfer A. Pharmacological vitreolysis. Dev Ophthalmol 2007; 39: 149-156.
64. Hermel M, Mahgoub M, Youssef T, Azrak MI, Raza H, All-dredge C, et al. Safety profile of the intravitreal streptoki-nase-plasmin complex as an adjuvant to vitrectomy in the rabbit. Graefes Arch Clin Exp Ophthalmol 2006; 244: 996-1002.
65. Gandorfer A, Ulbig M, Kampic A. Plasmin-assisted vitrectomy eliminates cortical vitreous remmants. Eye 2002; 16: 95-97.
66. Uemura A, Nakamura M, Kachi S, Nishizawa Y, Asami T, Miyake Y, et al. Effect of plasmin on laminin and fibronec-tin during plasmin-assisted vitrectomy. Arch Ophthalmol 2005; 123: 209-213.
67. Gandorfer A, Priglinger S, Schebitz K Vitreoretinal morphology of plasmin-treated human eyes. Am J Ophthalmol 2002; 133:156-159.
68. Gandorfer A. Enzymatic vitreous disruption. Eye, 2008, 22: 1273-1277.